Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
87,819,638
-
Total 13F shares
-
7,154,013
-
Share change
-
-41,509
-
Total reported value
-
$13,234,773
-
Price per share
-
$1.85
-
Number of holders
-
36
-
Value change
-
+$56,990
-
Number of buys
-
15
-
Number of sells
-
6
Institutional Holders of COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) as of Q4 2023
As of 31 Dec 2023,
COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,154,013 shares.
The largest 10 holders included
Pathstone Holdings, LLC, AIGH Capital Management LLC, VANGUARD GROUP INC, Worth Venture Partners, LLC, CARLSON CAPITAL L P, Kestra Advisory Services, LLC, AMERICAN FINANCIAL GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MERCER GLOBAL ADVISORS INC /ADV, and COMMONWEALTH EQUITY SERVICES, LLC.
This page lists
36
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.